[1]
Fucharoen S, Winichagoon P. Hemoglobinopathies in southeast Asia. Hemoglobin 1987; 11(1): 65-88.
[2]
Smith CH. Smith’s blood diseases of infancy and childhood. Saint Louis: Mosby 1978.
[3]
Giardina P, Forget B. Thalassemia syndromes. Hematol Basic Principl Pract 2008; 5: 535-63.
[4]
Rachmilewitz EA, Giardina PJ. How I treat thalassemia. Blood 2011; 118(13): 3479-88.
[5]
Ghotbi N, Tsukatani T. Evaluation of the national health policy of thalassaemia screening in the Islamic Republic of Iran. East Mediterr Health J 2005; 11(3): 308-18.
[6]
Akolekar R, Beta J, Picciarelli G, Ogilvie C, d’Antonio F. Procedure‐related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta‐analysis. Ultrasound Obstet Gynecol 2015; 45(1): 16-26.
[7]
Berry SM, Stone J, Norton ME, Johnson D, Berghella V. Medicine SfM-F. Fetal blood sampling. AJOG 2013; 209(3): 170-80.
[8]
Benn P, Cuckle H, Pergament E. Non‐invasive prenatal testing for aneuploidy: current status and future prospects. Ultrasound Obstet Gynecol 2013; 42(1): 15-33.
[9]
Bianchi DW, Flint AF, Pizzimenti MF, Knoll J, Latt SA. Isolation of fetal DNA from nucleated erythrocytes in maternal blood. Proc Natl Acad Sci USA 1990; 87(9): 3279-83.
[10]
Lo YD, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. The Lancet 1997; 350(9076): 485-7.
[11]
Wright CF, Burton H. The use of cell-free fetal nucleic acids in maternal blood for non-invasive prenatal diagnosis. Hum Reprod Update 2009; 15(1): 139-51.
[12]
Xue X, Teare MD, Holen I, Zhu YM, Woll PJ. Optimizing the yield and utility of circulating cell-free DNA from plasma and serum. Clin Chim Acta 2009; 404(2): 100-4.
[13]
Jorgez CJ, Bischoff FZ. Improving enrichment of circulating fetal DNA for genetic testing: size fractionation followed by whole gene amplification. Fetal Diagn Ther 2009; 25(3): 314-9.
[14]
Finning K, Martin P, Summers J, Massey E, Poole G, Daniels G. Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study. BMJ 2008; 36(7648): 816-8.
[15]
Legler TJ, Liu Z, Mavrou A, et al. Workshop report on the extraction of foetal DNA from maternal plasma. Prenat Diagn 2007; 27(9): 824-9.
[16]
Dhallan R, Au W-C, Mattagajasingh S, et al. Methods to increase the percentage of free fetal DNA recovered from the maternal circulation. JAMA 2004; 291(9): 1114-9.
[17]
Xu X-P, Gan H-Y, Li F-X, et al. A method to quantify cell-free fetal DNA fraction in maternal plasma using next generation sequencing: its application in non-invasive prenatal chromosomal aneuploidy detection. PLoS One 2016; 11(1): e0146997.
[18]
Kitagawa Y, Sugihara R. Genetic chromosome test management system, test management server, client terminal, genetic chromosome test management method, and program. Google Patents 2016.
[19]
Hudecova I, Chiu RW. Non-invasive prenatal diagnosis of thalassemias using maternal plasma cell free DNA. Best Pract Res Clin Obstet Gynaecol 2017; 39: 63-73.
[20]
Hahn S, Zhong XY, Holzgreve W. Recent progress in non-invasive prenatal diagnosis. Paper presented at. Semin Fetal Neonatal Med 2008; 13(2): 57-62.
[21]
Keshavarz Z, Moezzi L, Ranjbaran R, et al. Evaluation of a modified DNA extraction method for isolation of cell-free fetal DNA from maternal serum. AJMB 2015; 7(2): 85.
[22]
Douglas GW, Thomas L, Carr M, Cullen NM, Morris R. Trophoblast in the circulating blood during pregnancy. AJOG 1959; 78: 960-73.
[23]
Hahn S, Sant R, Holzgreve W. Fetal cells in maternal blood: current and future perspectives. Mol Hum Reprod 1998; 4(6): 515-21.
[24]
Beaudet AL. Using fetal cells for prenatal diagnosis: history and recent progress. Paper presented at: American Journal
of Medical Genetics Part C: Seminars in Medical Genetics. 2016.
[25]
Cheng W-L, Hsiao C-H, Tseng H-W, Lee T-P. Noninvasive prenatal diagnosis. Taiwan J Obstet Gynecol 2015; 54(4): 343-9.
[26]
Hatt L, Brinch M, Singh R, et al. Characterization of fetal cells from the maternal circulation by microarray gene expression analysis-Could the extravillous trophoblasts be a target for future cell-based non-invasive prenatal diagnosis? Fetal Diagn Ther 2013; 35(3): 218-27.
[27]
D'Souza E, Ghosh K, Colah R. A comparison of the choice of monoclonal antibodies for recovery of fetal cells from maternal blood using FACS for noninvasive prenatal diagnosis of hemoglobinopathies . Cytometry Part B: Clinical
Cytometry. 2009; 76(3): 175-80.
[28]
Samura O, Sekizawa A, Zhen DK, Falco VM, Bianchi DW. Comparison of fetal cell recovery from maternal blood using a high density gradient for the initial separation step: 1.090 versus 1.119 g/ml. Prenat Diagn 2000; 20(4): 281-6.
[29]
Prieto B, Alonso R, Paz A, et al. Optimization of nucleated red blood cell (NRBC) recovery from maternal blood collected using both layers of a double density gradient. Prenat Diagn 2001; 21(3): 187-93.
[30]
avanagh D, Kersaudy-Kerhoas M, Dhariwal R, Desmulliez M. Current and emerging techniques of fetal cell separation from maternal blood. Chromatogr B 2010; 878(22): 1905-11.
[31]
Ponnusamy S, Mohammed N, Ho S, et al. In vivo model to determine fetal-cell enrichment efficiency of novel noninvasive prenatal diagnosis methods. Prenat Diagn 2008; 28(6): 494-502.
[32]
Di Naro E, Ghezzi F, Vitucci A, et al. Prenatal diagnosis of β-thalassaemia using fetal erythroblasts enriched from maternal blood by a novel gradient. Mol Hum Reprod 2000; 6(6): 571-4.
[33]
Brittain T. Molecular aspects of embryonic hemoglobin function. Mol Aspects Med 2002; 23(4): 293-42.
[34]
Han JY, Kim KH, Park JI, Kim IH, Je GH. Detection of fetal erythroid cells from maternal blood using fluorescence in situ hybridization and liquid culture. J Korean Med Sci 2001; 16(2): 145-9.
[35]
Peng W, Takabayashi H, Ikawa K. Whole genome amplification from single cells in preimplantation genetic diagnosis and prenatal diagnosis. Eur J Obstet Gynecol Reprod Biol 2007; 131(1): 13-20.
[36]
Normand E, Qdaisat S, Bi W, et al. Comparison of three whole genome amplification methods for detection of genomic aberrations in single cells. Prenat Diagn 2016; 36(9): 823-30.
[37]
Chiu RW, Lau TK, Leung TN, Chow KC, Chui DH, Lo YD. Prenatal exclusion of β thalassaemia major by examination of maternal plasma. Lancet 2002; 360(9338): 998-1000.
[38]
Li Y, Di Naro E, Vitucci A, Zimmermann B, Holzgreve W, Hahn S. Detection of paternally inherited fetal point mutations for β-thalassemia using size-fractionated cell-free DNA in maternal plasma. JAMA 2005; 293(7): 843-9.
48
2
1
1